[{"Assets_0_Q1_USD":"46838300000.0","CIK":"59478","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"1.49","EarningsPerShareDiluted_1_Q1_USD":"1.49","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"282857000000.0","MinorityInterest_0_Q1_USD":"200600000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"1697400000.0","NetIncomeLoss_1_Q1_USD":"1355300000.0","OfficialName":"Eli Lilly and Company Common Stock","ProfitLoss_1_Q1_USD":"1355300000.0","RevenuesConverted_1_Q1_USD":"6805600000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":"7099300000.0","StockholdersEquity_0_Q1_USD":"6898700000.0","Ticker":"LLY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"912400000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"908800000.0","filed":"20210430","footnote":null,"form":"10-Q","fp":"Q1","fy":"2021.0","name":"ELI LILLY & CO","period":"20210331","qtrs":"1","uom":"USD"}]